Idiopathic chronic eosinophilic pneumonia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

🩺

1Specialists

Regulatory Watchboard

No FDA or trial events recorded yet for Idiopathic chronic eosinophilic pneumonia.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Idiopathic chronic eosinophilic pneumonia.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Imatinib Mesylate

(IMATINIB MESYLATE)Orphan drugstandard

Apotex Corp

12.1 Mechanism of Action Imatinib mesylate is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase, the constitutive abnormal...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Idiopathic chronic eosinophilic pneumonia.
Search all trials →

Search clinical trials for Idiopathic chronic eosinophilic pneumonia →

Recent News & Research

No recent news articles indexed yet for Idiopathic chronic eosinophilic pneumonia.
Search PubMed for Idiopathic chronic eosinophilic pneumonia →

Browse all Idiopathic chronic eosinophilic pneumonia news →

Specialist Network

Top 1 by expertise

Selsabil Daboussi

Military Hospital of Instruction of Tunis

Score 02 pubs

View all Idiopathic chronic eosinophilic pneumonia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰